News | Prostate Cancer | January 18, 2017

PI-RADS Named Best Clinical Research Paper by European Urology

Prostate Imaging Reporting and Data System provides standardized reporting scheme

prostate cancer, PI-RADS, best clinical research paper, European Urology

January 18, 2017 — An article promoting standardized imaging efforts to improve diagnosis and treatment of prostate cancer has been selected as the best clinical research paper published in European Urology

“PI-RADS Prostate Imaging — Reporting and Data System: 2015, Version 2,” written by members of the MR Prostate Imaging Reporting and Data System (PI-RADS) Steering Committee, was published January 2016 in the official journal of the European Association of Urology (EAU). The article provides updated information for the acquisition and standardized interpretation and reporting of multiparametric magnetic resonance imaging (MRI) of the prostate to detect potentially life-threatening cancers.

“Since the publication of this paper last year, the newest version of PI-RADS has been welcomed with open arms and rapidly implemented by the prostate cancer medical community. The positive impact has been tremendous on both clinical care and research concerning the risk of clinically significant prostate cancer that may require biopsy and treatment,” said Jeffrey C. Weinreb, M.D., FACR, co-chair of the MR Prostate Imaging Reporting and Data System (PI-RADS) Steering Committee. Written for medical professionals, the online document along with the European Urology article represent an international scientific consensus, he added. Weinreb noted the steering committee was honored that its efforts received this international distinction. The award will be presented at the EAU annual meeting in March.

The American College of Radiology (ACR) formed a joint effort with AdMeTech Foundation and the European Society of Urogenital Radiology (ESUR) to expedite the transfer of high-quality MRI from laboratories to patients to address a major need in prostate cancer care — reducing unnecessary biopsies and treatment.

Members of the steering committee and authors of the journal article include Weinreb; Jelle O. Barentsz, M.D., Ph.D. (co-chair); Peter L. Choyke, M.D., FACR; François Cornud, M.D.; Masoom A. Haider, M.D.; Katarzyna J. Macura, M.D., Ph.D., FACR; Daniel Margolis, M.D.; Mitchell D. Schnall, M.D., Ph.D., FACR; Clare M. Tempany, M.D.; Harriet C. Thoeny, M.D.; and Sadhna Verma, M.D.

For more information: www.europeanurology.com

References

Weinreb, J.C., Barentsz, J.O., Choyke, P.L., Cornud, F., et al. "PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2," European Urology. Published Jan. 1, 2016. DOI: 10.1016/j.eururo.2015.08.052

Related Content

#prostatecancer During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate cancer in Sweden than in previous years.

Getty Images

News | Prostate Cancer | April 30, 2021
April 30, 2021 — During the first wave of the corona pandemic, 36 percent fewer men were diagnosed with prostate canc
Change Healthcare unveiled InterQual 2021, the latest edition of the company’s flagship clinical decision support solution.
News | Clinical Decision Support | April 22, 2021
April 22, 2021 — Change Healthcare unveiled...
Elsevier’s STATdx, a leading radiology diagnostic decision support solution, now includes select Merit-Based Incentive Payment System (MIPS) Measures validated by MDinteractive
News | Clinical Decision Support | April 02, 2021
April 2, 2021 — Elsevier, a global leader in research publishing and information analytics, announced a partnership w
A national screening program targeted at those men who are genetically pre-disposed to prostate cancer, and involving a blood test and magnetic resonance imaging (MRI) scan before an invasive biopsy, could prevent one in six prostate cancer deaths and significantly reduce over-diagnosis, finds a new study led by UCL researchers.

Getty Images

News | Prostate Cancer | March 15, 2021
March 15, 2021 — A national screening program targeted at those men who are genetically pre-disposed to...
Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy.  The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Axial fused PET/CT image shows intense uptake (arrowhead) in the deep pelvis corresponding to the left lobe of the prostate in a 62-year-old with a history of prostate cancer treated with radiation therapy. The CT scan does not show the tumor. Image courtesy of the the Radiological Society of North America.

Feature | Treatment Planning | March 05, 2021 | By Melinda Taschetta-Millane
The decision to offer...
Immunotherapy-based precision medicine clinical trials being developed

Getty Images

News | Prostate Cancer | February 16, 2021
February 16, 2021 — Black men die more often of prostate cancer yet, paradoxically, have greater survival benefits fr
Phase III clinical trial of men with a clinical suspicion of prostate cancer finds MRI with targeted biopsies to be more accurate at diagnosis and less intrusive than current standard
News | Magnetic Resonance Imaging (MRI) | February 08, 2021
February 8, 2021 — The results of a Phase III randomized clinical trial have shown that when it comes to detecting cl

Images in 69-year-old man with biopsy-confirmed Gleason score 7 (3+4) prostate cancer. (a) Pretreatment axial T2-weighted fast spin-echo MRI scan (repetition time msec/echo time msec, 3820/97) shows tumor in midline anterior transition zone (arrow). (b) Intraoperative MRI scan shows contoured rectal wall (red line), prostate margin (blue outline), and region of interest (orange outline). Because the urethra was included in planned treatment volume, a suprapubic catheter was placed for continuous bladder drainage during treatment. (c) Intraoperative MRI scan shows focused ultrasound beam path (blue) overlaid on treatment plan. Rectangles illustrate each sonication spot. (d) Thermal map image obtained during treatment with heat deposition color coded in red overlaid on sonication spot. (e) Axial gadopentetate dimeglumine-enhanced MRI scan (230/2.97) obtained immediately after treatment shows devascularized ablated volume (arrows). (f) Corresponding T2-weighted fast spin-echo MRI scan (3820/97) at 5 months after ablation shows complete involution of transition zone. All seven cores from treatment area margins were negative for cancer at biopsy. Image courtesy of the Radiological Society of North America

News | Prostate Cancer | February 05, 2021
February 5, 2021 — A technique that delivers...